A clinical‑stage biotechnology company focused on developing immunotherapy treatments for autoimmune diseases, with its lead candidate targeting secondary progressive multiple sclerosis. The firm’s research centers on modulating the innate immune system using proprietary compounds designed to alter ...
2 members of Congress have disclosed 2 trades in Innate Immunotherapeutics Ltd (INNTF), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-06-12 | JOHN ABNEY CULBERSON | buy | $1K – $15K |
| 2015-10-21 | Chris Collins | buy | $1M – $5M |